Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125419272 | 12541927 | 2 | F | 20160707 | 20160708 | 20160719 | PER | US-ASTRAZENECA-2016SE61900 | ASTRAZENECA | 0.00 | F | Y | 128.80000 | KG | 20160719 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125419272 | 12541927 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160 4.5, 2 PUFFS TWICE A DAY | 3001166C00 | 21929 | |||||||||
| 125419272 | 12541927 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 125419272 | 12541927 | 3 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG AT NIGHT | 0 | ||||||||||
| 125419272 | 12541927 | 4 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125419272 | 12541927 | 5 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 100.0MG UNKNOWN | 0 | 100 | MG | ||||||||
| 125419272 | 12541927 | 6 | C | PHENTERMINE HCL | PHENTERMINE HYDROCHLORIDE | 1 | Oral | DAILY | 0 | ||||||||||
| 125419272 | 12541927 | 7 | C | APRAZOLAM | 2 | Oral | 0 | ||||||||||||
| 125419272 | 12541927 | 8 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
| 125419272 | 12541927 | 9 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 500.0MG UNKNOWN | 0 | 500 | MG | ||||||||
| 125419272 | 12541927 | 10 | C | EPIPEN | EPINEPHRINE | 1 | 0 | ||||||||||||
| 125419272 | 12541927 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1000 DAILY | 0 | ||||||||||
| 125419272 | 12541927 | 12 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | Topical | 60 G | 0 | ||||||||||
| 125419272 | 12541927 | 13 | C | SMOOTHLAX | 2 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125419272 | 12541927 | 1 | Asthma |
| 125419272 | 12541927 | 2 | Blood pressure abnormal |
| 125419272 | 12541927 | 3 | Asthma |
| 125419272 | 12541927 | 4 | Bipolar disorder |
| 125419272 | 12541927 | 5 | Bipolar disorder |
| 125419272 | 12541927 | 6 | Inadequate diet |
| 125419272 | 12541927 | 7 | Anxiety |
| 125419272 | 12541927 | 8 | Back pain |
| 125419272 | 12541927 | 9 | Back pain |
| 125419272 | 12541927 | 10 | Hypersensitivity |
| 125419272 | 12541927 | 11 | Vitamin D deficiency |
| 125419272 | 12541927 | 12 | Abdominal discomfort |
| 125419272 | 12541927 | 13 | Constipation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125419272 | 12541927 | Arthropathy | |
| 125419272 | 12541927 | Body height decreased | |
| 125419272 | 12541927 | Drug dose omission | |
| 125419272 | 12541927 | Dyspnoea | |
| 125419272 | 12541927 | Faeces hard | |
| 125419272 | 12541927 | Feeling abnormal | |
| 125419272 | 12541927 | Infection | |
| 125419272 | 12541927 | Product quality issue | |
| 125419272 | 12541927 | Visual acuity reduced | |
| 125419272 | 12541927 | Weight increased | |
| 125419272 | 12541927 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125419272 | 12541927 | 1 | 20160401 | 0 |